OUR CHALLENGE

Sustained delivery of Active Pharmaceutical Ingredients (APIs)
APPLICATION + API

Treatment optimization -> Bioavailability
Improves the integration of treatment into patients’ daily lives -> therapeutic adherence

THE NEED

CURRENT SOLUTION : Synthetic polymers/plastics

• Release with burst effect
• Incompatible with the loading of many APIs

Peptides & therapeutic proteins, small hydrophilic molecules

OUR SOLUTION

Native albumin-based materials for sustained drug delivery
Injectable microparticles
Native human albumin

Most abundant plasma protein

• Biocompatible, biodegradable, non-immunogenic
• Available raw materials (GMP grade)
• Natural carrier protein (established therapeutic use for drug delivery)

Non-denaturing process for the production of protein-based materials

Patent : European patent (2019), PCT extension (2020), National phases Expertise

Material Ι Process Ι Application

Exclusive licensing agreement concluded with Conectus 2024

OUR TECHNOLOGY

Non-denaturing process for the preparation of protein-based materials

Albumin + Salt

Evaporation 37°C

Washing (water)

100% Native Albumin
EXPERTISE
Formulation development Drug encapsulation

MEMBRANES

COMPACT MATERIALS

SPONGES

EXTRUDABLE MATERIALS

MICROPARTICLES